Minerva Neurosciences, Inc. (NERV)

Minerva Neurosciences, Inc. (NERV) is a healthcare company (biotechnology) based in the United States. The share price is $2.14, down 2.73% on the day, which values the company at $106.65M. Price as of 17 Nov 2026, 17:43 UTC, from Yahoo Finance.

Key facts

Share price
$2.14−2.73% today
Market value
$106.65M
200-week average
$4.0247% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Minerva Neurosciences, Inc. in more detail

NERV trades at -5.1× next year's expected earnings. It sits 47% below its 200-week average of $4.02.

Worth checking: Share count keeps rising.

1 of the superinvestors tracked here hold NERV, including Andrew Spokes (0.0% of the portfolio).

Superinvestors holding NERV

1 of the investors tracked here report a position in their latest 13F filing.

Minerva Neurosciences, Inc. (NERV): questions and answers

What is Minerva Neurosciences, Inc.'s market cap?

Minerva Neurosciences, Inc. is valued at $106.65M at a share price of $2.14.

Is NERV above its 200-week moving average?

No. NERV is 46.8% below its 200-week average of $4.02. Long-term investors watch that line because strong companies rarely trade below it for long.

Does NERV pay a dividend?

Minerva Neurosciences, Inc. does not currently pay a regular dividend.

Which famous investors own NERV?

In their latest quarterly filings, Andrew Spokes (0.0% of the portfolio) hold NERV. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Minerva Neurosciences, Inc. (NERV) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/NERV

Underlying data: Yahoo Finance; company filings with the SEC.